Find out more about the members of TAC D by reading their biographies.

Professor Gary McVeigh (Chair)

Professor of Cardiovascular Medicine, Queen's University Belfast and Consultant Physician, Belfast Health and Social Care Trust

Read more

Gary is a Consultant Physician/Clinical Pharmacologist in the Belfast Health and Social Care Trust and Professor of Cardiovascular Medicine at Queen's University Belfast. Gary qualified from Queen's University and trained in Belfast and Minneapolis, USA.

His major clinical and academic interests relate to cardiovascular complications associated with hypertension, diabetes mellitus and hyperlipidaemia. He has served as a member of the Executive Committee of the British Hypertension Society and is currently a member of the Guidelines and Information Committee. Gary was Regional Advisor for Northern Ireland and member of council for the Royal College of Physicians of Edinburgh. Gary chairs the Drugs and Therapeutics and New Drugs Committees and is the lead clinician for Therapeutic reviews in the Belfast Trust. He is the Training Programme Director for Clinical Pharmacology and Therapeutics in Northern Ireland.

Gary was former Vice Chair of Technology Appraisal Committee C and is currently Standing Chair of an internal Guideline Development Group for NICE.

Dr Lindsay Smith, BSc MClinSci PhD MD FRCP FRCGP FHEA (Vice Chair)

General Practitioner, Westlake Surgery, Somerset

Read more

Lindsay Smith has been a General Practitioner in Somerset for over 25 years. During this time he has undertaken primary care research through both academic departments and research general practices. He has previously been a Consultant senior lecturer in general practice and primary care. Currently he is an honorary senior lecturer at Bristol University, a CCG Patient Safety Lead.

He has previously worked for NICE as a member of its TA appeals committee, its QOF advisory committee and various GDGs. Additionally he has been a member of its Quality Standards Advisory Committee, its CG Rapid Updates Standing Committee and a member of its Suspected Cancer GDG.

Dr Nabeel Alsindi

GP Clinical Lead for Primary care, Doncaster CCG

Read more

Biography to follow.

Dr Aomesh Bhatt

Director of Regulatory and Medical Affairs, Europe and North America, Reckitt Benckiser

Read more

Biography to follow.

Professor David Bowen, MA MB BChir MD MRCP FRCPath

Consultant Haematologist, Leeds Teaching Hospitals NHS trust

Read more

David qualified from Cambridge University and Middlesex Hospital, London. He trained in Haematology in London and Cardiff, with first his Consultant appointment in Dundee,then in Leeds where he has worked since 2005. His clinical expertise is in myeloid malignancies, with research interests in the etiology, molecular basis and clinical trial management of these diverse and rare cancers.

He has chaired the National Cancer Research Institute Myelodysplastic Syndromes (MDS) subgroup and the British Committee for Standards in Haematology Guideline group for MDS. He co-chairs the European Myelodysplastic Syndrome Registry programme, accruing data for clinical effectiveness of management interventions in community-based practice.

Dr Matthew Bradley

Therapy Area Leader, Global Health Outcomes, GlaxoSmithKline

Read more

Matt is Vice President, Therapy Area Head for Value Evidence & Outcomes at GlaxoSmithKline. Prior joining GSK, Matt was a Value Demonstration Leader for AstraZeneca Global Research and Development. He has previously been responsible for the coordination and delivery of an integrated programme of HTA across the Sanofi-Aventis portfolio in the UK and has also worked for Pfizer. Prior to moving into the Pharmaceutical Industry he was a Senior Research Fellow at the NHS Centre for Reviews and Dissemination (CRD), a lead reviewer for the Cochrane Collaboration, an author of strategic reports for the NHS HTA programme, the Department of Health and the Prime Minister's Office (UK Government).

Matthew has previously chaired the Association of British Pharmaceutical Industries TDA User Group, been a peer reviewer for the NHS HTA programme and sat on the New Medicines Group (NMG) for the All Wales Medicines Strategy Group.

Dr Ian Davidson

Senior Lecturer in Physiotherapy, Manchester Metropolitan University

Read more

Ian has been a clinical and academic physiotherapist for more than 30 years. He has worked as an academic at the Manchester School of Physiotherapy (affiliated to the University of Manchester), the School of Nursing Midwifery and Social work at the University of Manchester and is currently working as a Senior Lecturer at the School of Physiotherapy at Manchester Metropolitan University.

He has served on several professional committees and boards and has recently stepped down as a panel member of the fitness to practice committee at the Health Care and Professions Council (HCPC) after 12 years of service. His clinical interests are in musculo-skeletal and neurological disorders. His research interests centre on intervention studies assessing the effect of physiotherapy on stroke, Guillain-Barré syndrome and migraine headache.

Professor Simon Dixon

Professor of Health Economics, University of Sheffield

Read more

Simon Dixon is the Director of the Health Economics and Decision Science (HEDS) section of the School of Health and Related Research (ScHARR) within the University of Sheffield. Most of his work has examined the cost-effectiveness of health technologies. A separate stream of work examining the use of willingness to pay to value non-health benefits of health care is also ongoing.

He undertakes work for the Department of Health's Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) based in Sheffield/York. He teaches on three masters programmes within ScHARR and supervises several PhD students.

Susan Dutton

Senior Medical Statistician, Oxford Clinical Trials Research Unit

Read more

Susan is a senior medical statistician and the lead statistician of the Oxford Clinical Trials Research Unit (OCTRU), a UKCRC Registered Clinical Trials Unit. The scope of OCTRU is to design, conduct and report in both early and later phase clinical trials in surgery, musculoskeletal sciences, respiratory medicines, gastroenterology and oncology including development pathways and the evaluation of new health technologies in surgery and interventional procedures; trauma, rehabilitation and conservative management; respiratory medicine/intervention and randomised trials; pharmaceuticals, particularly in oncology; the management of inflammation; and biomarkers to refine treatment strategies.

Susan has a BSc in Mathematics from Durham University and an MSc in Biometry from the University of Reading. She has worked as a medical statistician within academia and has experience in the design, analysis and reporting of various clinical trials and epidemiological studies. Susan joined the Centre for Statistics in Medicine at the University of Oxford in January 2007 to work as part of a team of medical statisticians providing statistical support for clinical trials in oncology. In 2013 Susan was appointed to be the Statistical Lead of the Oxford Clinical Trials Research Unit (OCTRU). Susan provides statistical input into a variety of Phase I-IV clinical trials from providing advice early in the development of the research, through designing the trial for grant application, through set-up, data collection, analysis and publication. Susan provides statistical oversight of trials and staff in OCTRU. Susan also participates in the methodological research undertaken by the Centre for Statistics in Medicine.

Professor Rachel Elliott

Professor of Health Economics, University of Manchester

Read more

Biography to follow

Gillian Ells, BPharm PGDip MSc

Prescribing Advisor - Commissioning. Hastings and Rother Clinical Commissioning Group and Eastbourne, Hailsham and Seaford Clinical Commissioning Group

Read more

Gillian Ells is a pharmacist working for two clinical commissioning groups on the south east coast of England. Her previous experience includes working in both the hospital and the community sector.

She has spent the past 16 years in primary care as a pharmaceutical advisor and now specialises in the commissioning of new drug treatments and management of the local health economy drug formulary. Gillian has recently completed a Masters in Health Economics and Health Policy at Birmingham University.

Professor Paula Ghaneh

Professor and Honorary Consultant Surgeon, University of Liverpool

Read more

Paula Ghaneh is a Professor of Surgery at the University of Liverpool and an Honorary Consultant Surgeon at the Royal Liverpool University Hospital.

Her clinical specialty is hepato-pancreato-biliary surgery. Her research interests are pancreatic cancer and clinical trials. She is the Deputy Director of the Cancer Research UK Liverpool Cancer Trials Unit. She is a member of the NCRI upper GI CSG and pancreatic cancer subgroup.

Dr Peter Hall

Senior Clinical Lecturer in Medical Oncology, University of Edinburgh

Read more

Biography to follow

Rebecca Harmston

Lay Member

Read more

Biography to follow

Sumithra Maheswaran, MPharm (Hons) MBA MRPharmS

Trust Pharmacist, London Ambulance Service NHS Trust

Read more

Biography to follow

Dr David Meads

Associate Professor, Health Economics, University of Leeds

Read more

Biography to follow

Malcolm Oswald

Lay member

Read more

Malcolm works as an independent consultant. His background is in systems analysis, analysing what people and organisations providing health care do and also what information they need to do it. Since the late 1990s, he has specialised in information governance, working mostly for National bodies in England and Scotland specifying the rules that control who accesses confidential patient information in systems. This involves interpreting and applying law and policy, consulting clinicians and patient/public representatives.

Malcolm has completed a PhD in Bioethics and Medical Jurisprudence. His thesis explores how, in a democracy, we should decide how resources are allocated to health care, analysing competing theories from philosophy, economics and other disciplines. In 2011, he co-authored the Royal College of General Practitioners' guidance on ethical commissioning (“Making Difficult Choices”).

Professor Oluwafemi Oyebode

Professor of Psychiatry & Consultant Psychiatrist, The National Centre for Mental Health

Read more

Femi graduated in Medicine in 1977. He has been Consultant Psychiatrist in Birmingham since 1986. He is currently Professor of Psychiatry at the University of Birmingham.

He is on the Editorial Boards of the British Journal of Psychiatry, the Psychiatric Bulletin and Advances in Psychiatric Treatment. His research interests include Clinical Psychopathology, Medical Humanities and Medical Ethics.

Dr Paula Parvulescu, MD MSc MPH FFPH

Consultant in Public Health Medicine, Liverpool City Council

Read more

Paula is a Consultant in Public Health Medicine specialised in healthcare public health, working for Liverpool City Council. In her role, she works with NHS commissioners to make sure that a population health approach is undertaken and pathways and models of care are based on best available evidence.

Paula trained as a Public Health Physician in Romania and holds a MSc degree in Health Policy, Economics and Management from Maastricht University in the Netherlands. In her previous roles, Paula worked as a health economics and outcomes research consultant and in academia as a public health lecturer.

William Turner

Consultant Urologist, Cambridge University Hospitals NHS Foundation Trust

Read more

Biography to follow

More information

Find out more about the committee and read papers from previous meetings.

About the Technology Appraisal committee


Get involved

Find out when TAC meetings are held and register to attend.